The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Breast Cancer Predictive Genetic Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Breast Cancer Predictive Genetic Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Predictive Genetic Testing in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Breast Cancer Predictive Genetic Testing market. High Penetrant Genes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intermediate Penetrant Genes segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Breast Cancer Predictive Genetic Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Breast Cancer Predictive Genetic Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Predictive Genetic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Cancer Predictive Genetic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Cancer Predictive Genetic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Predictive Genetic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Cancer Predictive Genetic Testing covered in this report include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics, etc.
The global Breast Cancer Predictive Genetic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Global Breast Cancer Predictive Genetic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Predictive Genetic Testing market, Segment by Type:
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Global Breast Cancer Predictive Genetic Testing market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Predictive Genetic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Breast Cancer Predictive Genetic Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Predictive Genetic Testing in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Breast Cancer Predictive Genetic Testing market. High Penetrant Genes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intermediate Penetrant Genes segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Breast Cancer Predictive Genetic Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Breast Cancer Predictive Genetic Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Predictive Genetic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Cancer Predictive Genetic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Cancer Predictive Genetic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Predictive Genetic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Cancer Predictive Genetic Testing covered in this report include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics, etc.
The global Breast Cancer Predictive Genetic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Global Breast Cancer Predictive Genetic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Predictive Genetic Testing market, Segment by Type:
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Global Breast Cancer Predictive Genetic Testing market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Predictive Genetic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Breast Cancer Predictive Genetic Testing
1.1 Breast Cancer Predictive Genetic Testing Market Overview
1.1.1 Breast Cancer Predictive Genetic Testing Product Scope
1.1.2 Breast Cancer Predictive Genetic Testing Market Status and Outlook
1.2 Global Breast Cancer Predictive Genetic Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Breast Cancer Predictive Genetic Testing Market Size by Region (2018-2029)
1.4 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Region (2018-2023)
1.5 Global Breast Cancer Predictive Genetic Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Breast Cancer Predictive Genetic Testing Market Size (2018-2029)
1.6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2018-2029)
1.6.2 Europe Breast Cancer Predictive Genetic Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size (2018-2029)
1.6.4 Latin America Breast Cancer Predictive Genetic Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size (2018-2029)
2 Breast Cancer Predictive Genetic Testing Market by Type
2.1 Introduction
2.1.1 High Penetrant Genes
2.1.2 Intermediate Penetrant Genes
2.1.3 Low Penetrant Genes
2.2 Global Breast Cancer Predictive Genetic Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Breast Cancer Predictive Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Breast Cancer Predictive Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Breast Cancer Predictive Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue Breakdown by Type (2018-2029)
3 Breast Cancer Predictive Genetic Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Breast Cancer Predictive Genetic Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Breast Cancer Predictive Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Breast Cancer Predictive Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Breast Cancer Predictive Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue Breakdown by Application (2018-2029)
4 Breast Cancer Predictive Genetic Testing Competition Analysis by Players
4.1 Global Breast Cancer Predictive Genetic Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2022)
4.3 Date of Key Players Enter into Breast Cancer Predictive Genetic Testing Market
4.4 Global Top Players Breast Cancer Predictive Genetic Testing Headquarters and Area Served
4.5 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Breast Cancer Predictive Genetic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.1.4 Roche Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.3.4 PerkinElmer Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.4.4 Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 Myriad Genetics
5.5.1 Myriad Genetics Profile
5.5.2 Myriad Genetics Main Business
5.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.5.4 Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Myriad Genetics Recent Developments
5.6 Iverson Genetics
5.6.1 Iverson Genetics Profile
5.6.2 Iverson Genetics Main Business
5.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.6.4 Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Iverson Genetics Recent Developments
5.7 Cancer Genetics
5.7.1 Cancer Genetics Profile
5.7.2 Cancer Genetics Main Business
5.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.7.4 Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Cancer Genetics Recent Developments
5.8 OncoCyte Corporation
5.8.1 OncoCyte Corporation Profile
5.8.2 OncoCyte Corporation Main Business
5.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.8.4 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.8.5 OncoCyte Corporation Recent Developments
5.9 NeoGenomics
5.9.1 NeoGenomics Profile
5.9.2 NeoGenomics Main Business
5.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.9.4 NeoGenomics Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.9.5 NeoGenomics Recent Developments
5.10 Invitae
5.10.1 Invitae Profile
5.10.2 Invitae Main Business
5.10.3 Invitae Breast Cancer Predictive Genetic Testing Products, Services and Solutions
5.10.4 Invitae Breast Cancer Predictive Genetic Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Invitae Recent Developments
6 North America
6.1 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Breast Cancer Predictive Genetic Testing Market Dynamics
11.1 Breast Cancer Predictive Genetic Testing Industry Trends
11.2 Breast Cancer Predictive Genetic Testing Market Drivers
11.3 Breast Cancer Predictive Genetic Testing Market Challenges
11.4 Breast Cancer Predictive Genetic Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
